全文获取类型
收费全文 | 10993篇 |
免费 | 561篇 |
国内免费 | 104篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 248篇 |
妇产科学 | 106篇 |
基础医学 | 1067篇 |
口腔科学 | 160篇 |
临床医学 | 759篇 |
内科学 | 3088篇 |
皮肤病学 | 149篇 |
神经病学 | 647篇 |
特种医学 | 380篇 |
外科学 | 2171篇 |
综合类 | 62篇 |
预防医学 | 234篇 |
眼科学 | 151篇 |
药学 | 781篇 |
中国医学 | 17篇 |
肿瘤学 | 1535篇 |
出版年
2023年 | 87篇 |
2022年 | 170篇 |
2021年 | 301篇 |
2020年 | 187篇 |
2019年 | 231篇 |
2018年 | 269篇 |
2017年 | 243篇 |
2016年 | 283篇 |
2015年 | 308篇 |
2014年 | 363篇 |
2013年 | 434篇 |
2012年 | 730篇 |
2011年 | 763篇 |
2010年 | 442篇 |
2009年 | 358篇 |
2008年 | 598篇 |
2007年 | 636篇 |
2006年 | 665篇 |
2005年 | 679篇 |
2004年 | 642篇 |
2003年 | 643篇 |
2002年 | 637篇 |
2001年 | 164篇 |
2000年 | 150篇 |
1999年 | 169篇 |
1998年 | 118篇 |
1997年 | 98篇 |
1996年 | 91篇 |
1995年 | 77篇 |
1994年 | 85篇 |
1993年 | 72篇 |
1992年 | 93篇 |
1991年 | 113篇 |
1990年 | 84篇 |
1989年 | 90篇 |
1988年 | 93篇 |
1987年 | 60篇 |
1986年 | 52篇 |
1985年 | 45篇 |
1984年 | 35篇 |
1983年 | 38篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 17篇 |
1979年 | 35篇 |
1978年 | 19篇 |
1973年 | 14篇 |
1971年 | 16篇 |
1969年 | 19篇 |
1966年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
82.
A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro 总被引:17,自引:0,他引:17
Nakagami Y Nishimura S Murasugi T Kubo T Kaneko I Meguro M Marumoto S Kogen H Koyama K Oda T 《European journal of pharmacology》2002,450(1):11-17
In order to determine whether 5-[bis(carboxymethyl) amino]-2-carboxy4-cyano-3-thiopheneacetic acid distrontium salt (S12911-2) inhibits bone resorption by acting on the differentiation and/or function of osteoclasts, its effects were assessed on the 1,25-dihydroxyvitamin D(3)-induced expression of carbonic anhydrase II and vitronectin receptor in chicken bone marrow cells, and on the resorbing activity of authentic rat osteoclasts cultured on bone slices. S12911-2 dose-dependently inhibited, after a 6-day exposure, the expression of carbonic anhydrase II and vitronectin receptor in stimulated osteoclasts (46% and 40%, respectively, at 10(-3) M Sr(2+), P<0.05). A pre-incubation of bone slices with S12911-2 induced a dose-dependent inhibition of bone resorbing activity from 32% at 10(-4) M Sr(2+) to 66% at 10(-3) M Sr(2+) (P<0.05 in each case). A continuous incubation (10(-3) M Sr(2+)) induced a greater inhibition of bone resorbing activity (73%, P<0.05). The inhibition of bone resorption obtained specifically with S12911-2 is related to an inhibition of the differentiation and resorbing activity of the osteoclasts. 相似文献
83.
Purpose To determine whether the amplitude of the s-wave on a multifocal electroretinogram (mfERG) is correlated with the degree of visual field depression in eyes with glaucoma.Methods Twenty patients (20 eyes) with glaucoma,ages 46 to 69 years, were studied. Twenty healthy volunteers (20 eyes) with normal intraocular pressure and with no eye diseases served as controls. The retinal sensitivities of the upper and lower visual fields of the glaucomatous eyes were determined with a Humphrey Field Analyzer. The severity of retinal sensitivity depression was rated as mild (Group A), intermediate (Group B), or severe (Group C). To record the s-wave, mfERGs were elicited by pseudorandom stimulation, with the stimulus alternating according to a binary m-sequence for base periods (bpds) of 13.3, 26.7, 53.3, 106.7, and 213.3ms. The mfERGwaves recorded from the upper and lower visual field were summed separately.Results In the control group, the s-wave in the summed mfERG was observed in all visual field halves at all bpds 53.3ms or longer. The s-wave amplitude at a bpd of 213.3ms was significantly larger than that at a bpd of 53.3ms (P < 0.05). The s-wave was also present in the glaucoma patients eyes, and the s-wave amplitude increased as the bpd increased. At bpds of 53.3, 106.7, and 213.3-ms, the mean s-wave amplitudes in Groups B and C were significantly smaller than those in the control group (P < 0.05, 0.01, and 0.05, respectively). At bpds of 53.3 and 106.7ms, the mean amplitude of the s-waves in Group C was significantly smaller than that in Group A (P < 0.05). At a bpd of 106.7ms, a significant correlation was observed between the retinal sensitivity and the s-wave amplitude (P < 0.05).Conclusions The significant correlation between the retinal sensitivity and the amplitude of the swave at a bpd of 106.7ms supports the suggestion that the s-wave originates from the retinal ganglion cells and their axons. The amplitude of the s-wave may serve as an objective indicator of the severity of retinal ganglion cell damage. Jpn J Ophthalmol 2004;48:215–221 © Japanese Ophthalmological Society 2004 相似文献
84.
A 45‐year‐old woman developed chest pain on the previous day. High‐attenuation mucus in the bronchus was found on the CT examination on admission, which led to a diagnosis of allergic bronchopulmonary mycosis. CT should be checked carefully for high‐attenuation mucus because this finding is highly specific for allergic bronchopulmonary mycosis. 相似文献
85.
86.
Hirotomo Dochi Satoru Kondo Takayuki Murata Masaki Fukuyo Asuka Nanbo Kousho Wakae WenPing Jiang Toshihide HamabeHoriike Mariko Tanaka Takumi Nishiuchi Harue Mizokami Makiko MoriyamaKita Eiji Kobayashi Nobuyuki Hirai Takeshi Komori Takayoshi Ueno Yosuke Nakanishi Miyako Hatano Kazuhira Endo Hisashi Sugimoto Naohiro Wakisaka ShinHun Juang Masamichi Muramatsu Atsushi Kaneda Tomokazu Yoshizaki 《Cancer science》2022,113(8):2862
87.
Takeyama K Ogura M Morishima Y Kasai M Kiyama Y Ohnishi K Mitsuya H Kawano F Masaki Y Sasaki T Chou T Yokozawa T Tobinai K;Lenograstim/Lymphoma Study Group 《Japanese journal of clinical oncology》2003,33(2):78-85
BACKGROUND: Peripheral blood stem cell (PBSC) reinfusion has been widely used for hematopoietic reconstitution after high-dose chemotherapy. However, the optimal dose of granulocyte colony-stimulating factor (G-CSF) for PBSC mobilization in combination with chemotherapy for autograft remains unknown. METHODS: To find the optimal dose of glycosylated G-CSF (lenograstim) for PBSC mobilization in combination with chemotherapy for aggressive non-Hodgkin's lymphoma (NHL), we conducted a dose-finding study on 43 newly diagnosed patients who had unfavorable prognostic factors. They received four to six courses of cyclophosphamide, doxorubicin, vincristine and prednisolone combined with lenograstim every 2 weeks (biweekly CHOP therapy). PBSC apheresis was started after the third course of biweekly CHOP therapy. Lenograstim was given daily from day 3 until the day of the last apheresis. The optimum dose of lenograstim was assessed based on mobilization efficacy and safety profiles at a daily single dose of 2, 5 and 10 microg/kg for eight patients in each level. RESULTS: The collected number of CD34+ cells in the first apheresis products was higher in the 5 microg/kg group than in the 2 microg/kg group (median, 4.22 x 10(6) vs 2.49 x 10(6) CD34+ cells/kg, P = 0.051). The highest dose of 10 microg/kg (median, 2.99 x 10(6) CD34+ cells/kg) failed to show a dose dependence in PBSC mobilization. The efficacy and safety of the 5 microg/kg dose were further confirmed in an additional 19 patients. CONCLUSIONS: The present study suggests that the recommended dose of lenograstim for PBSC mobilization with CHOP therapy in untreated NHL is 5 microg/kg. 相似文献
88.
89.
90.
Iida T Yasuda M Miyazawa M Fujita M Osamura RY Hirasawa T Muramatsu T Murakami M Saito K Mikami M 《Archives of gynecology and obstetrics》2008,277(6):539-546
Material and methods We analyzed the expression of hypoxia inducible factor-1α (HIF-1α) and glucose transporter-1 (GLUT-1) by immunohistochemistry
in ovarian serous and mucinous tumors from the point view of the histological characteristics and acquisition of malignancy.
A total of 102 ovarian tumors were examined, composed of 31 adenomas (serous 17 and mucinous 14), 32 borderline tumors (serous
13 and mucinous 19), and 39 adenocarcinomas (serous 21 and mucinous 18).
Results The overall positive ratios were as follows: HIF-1α, 74% of
adenomas, 91% of borderline tumors, and 100% of adenocarcinomas; and GLUT-1, 68% of adenomas, 95% of borderline tumors, and
100% of adenocarcinomas. Comparing serous tumors and mucinous tumors, there was no significant difference in the positive
ratios of HIF-1α and GLUT-1 of adenomas, borderline tumors, and adenocarcinomas. However, both markers were more strongly
expressed in serous adenocarcinomas (HIF-1α, 3 + 100%; GLUT-1, 3 + 76%) than in mucinous adenocarcinomas (HIF-1α, 3 + 61%;
GLUT-1, 3 + 28%). The results of immunoblotting and mRNA expression level analyses corresponded with those of immunohistochemical
expression profiles. DNA binding assay also demonstrated that HIF-1 is more commonly activated in serous adenocarcinomas than
in mucinous adenocarcinomas.
Conclusion HIF-1α and GLUT-1 expressions seemed to be coordinated to adapt ovarian tumor cells into hypoxic conditions in close association
with the acquisition of malignancy. We consider that the relatively strong expression of both markers in serous tumors compared
with mucinous tumors is related to the difference in their histological characteristics. 相似文献